FORBES-TATE for EMERGENT BIOSOLUTIONS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.4350/S.2792 - National Defense Authorization Act for Fiscal Year 2022, provisions related to biological and chemical defense and access to naloxone; S. 4231 (116th Congress) - Preparing for the Next Pandemic Act; Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| JERRY DRISCOLL | — |
| KRISTINA DUNKLIN | — |
| ELIZABETH GREER | — |
| FRANCESCA MCCRARY | — |
| EDWARD C. RENO | — |
| JEFFREY SADOSKY | — |
| WESLEY RYAN WELCH | — |
| DERRICK M WHITE | — |
| ZACHARY WILLIAMS | — |
Budget/Appropriations BUD
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R.4350/S.2792 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to biological and chemical defense and access to naloxone.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| JERRY DRISCOLL | — |
| KRISTINA DUNKLIN | — |
| ELIZABETH GREER | — |
| FRANCESCA MCCRARY | — |
| EDWARD C. RENO | — |
| JEFFREY SADOSKY | — |
| WESLEY RYAN WELCH | — |
| DERRICK M WHITE | — |
| ZACHARY WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.